New Generation Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-5,744,776
| Closed | -$4.94M | – | 23 |
|
|
2019
Q4 | $4.94M | Sell |
5,744,776
-197,094
| -3% | -$151K | 5.53% | 4 |
|
|
2019
Q3 | $3.39M | Sell |
5,941,870
-20,553
| -0.3% | -$11.1K | 3.17% | 10 |
|
|
2019
Q2 | $3.1M | Buy |
5,962,423
+1,689,202
| +40% | +$844K | 2.44% | 15 |
|
|
2019
Q1 | $1.92M | Buy |
4,273,221
+4,993
| +0.1% | +$2.33K | 1.35% | 28 |
|
|
2018
Q4 | $2.05M | Hold |
4,268,228
| – | – | 1.48% | 20 |
|
|
2018
Q3 | $2.26M | Buy |
4,268,228
+25,000
| +0.6% | +$13.4K | 1.35% | 25 |
|
|
2018
Q2 | $2.12M | Hold |
4,243,228
| – | – | 1.23% | 24 |
|
|
2018
Q1 | $1.79M | Buy |
4,243,228
+600,000
| +16% | +$241K | 1.11% | 25 |
|
|
2017
Q4 | $1.38M | Buy |
3,643,228
+429,633
| +13% | +$163K | 0.85% | 26 |
|
|
2017
Q3 | $1.16M | Hold |
3,213,595
| – | – | 0.71% | 27 |
|
|
2017
Q2 | $1.22M | Hold |
3,213,595
| – | – | 0.76% | 27 |
|
|
2017
Q1 | $1.45M | Hold |
3,213,595
| – | – | 1.04% | 25 |
|
|
2016
Q4 | $1.22M | Sell |
3,213,595
-4,571,152
| -59% | -$1.55M | 0.66% | 35 |
|
|
2016
Q3 | $2.08M | Buy |
7,784,747
+1,684,880
| +28% | +$427K | 1.18% | 24 |
|
|
2016
Q2 | $1.46M | Buy |
6,099,867
+2,590
| +0% | +$445 | 0.92% | 29 |
|
|
2016
Q1 | $695K | Hold |
6,097,277
| – | – | 0.36% | 36 |
|
|
2015
Q4 | $686K | Buy |
+6,097,277
| New | +$861K | 0.35% | 33 |
|
New Generation Advisors's GCVRZ Position: Q1 2020 in Review
New Generation Advisors sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 5,744,776 shares — an estimated $4.94M sold.
New Generation Advisors first reported a position in GCVRZ in Q4 2015 and held it in 17 quarters. The position peaked at $4.94M in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- New Generation Advisors reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- New Generation Advisors sold 5,744,776 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $4.94M.
- New Generation Advisors first reported a position in Sanofi Contingent Value Rights in Q4 2015 and held it in 17 quarters.
- New Generation Advisors's Sanofi Contingent Value Rights position peaked at $4.94M in Q4 2019.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on New Generation Advisors's 13F filing for Q1 2020, filed 15 May 2020.